- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Comparative and Functional Genomics
Volume 2009 (2009), Article ID 914762, 16 pages
Comparative Analyses of Transcriptional Profiles in Mouse Organs Using a Pneumonic Plague Model after Infection with Wild-Type Yersinia pestis CO92 and Its Braun Lipoprotein Mutant
1Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX 77555-1070, USA
2Virginia Bioinformatics Institute, Virginia Polytechnic and State University, Blacksburg, VA 24061, USA
Received 26 July 2009; Revised 28 September 2009; Accepted 18 October 2009
Academic Editor: Antoine Danchin
Copyright © 2009 Cristi L. Galindo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- T. V. Inglesby, D. T. Dennis, D. A. Henderson, et al., “Plague as a biological weapon: medical and public health management,” Journal of the American Medical Association, vol. 283, no. 17, pp. 2281–2290, 2000.
- F. Sebbane, D. Gardner, D. Long, B. B. Gowen, and B. J. Hinnebusch, “Kinetics of disease progression and host response in a rat model of bubonic plague,” American Journal of Pathology, vol. 166, no. 5, pp. 1427–1439, 2005.
- W. W. Lathem, S. D. Crosby, V. L. Miller, and W. E. Goldman, “Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 49, pp. 17786–17791, 2005.
- S. S. Bubeck, A. M. Cantwell, and P. H. Dube, “Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice,” Infection and Immunity, vol. 75, no. 2, pp. 697–705, 2007.
- I. Adkins, M. Köberle, S. Gröbner, E. Bohn, I. B. Autenrieth, and S. Borgmann, “Yersinia outer proteins E, H, P, and T differentially target the cytoskeleton and inhibit phagocytic capacity of dendritic cells,” International Journal of Medical Microbiology, vol. 297, no. 4, pp. 235–244, 2007.
- D. C. Cavanaugh and R. Randall, “The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of flea-borne plague,” Journal of Immunology, vol. 83, pp. 348–363, 1959.
- R. T. Dean and W. Jessup, Eds., Mononuclear Phagocytes: Physiology and Pathology, Elsevier, New York, NY, USA, 1985.
- Y. Du, R. Rosqvist, and A. Forsberg, “Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis,” Infection and Immunity, vol. 70, no. 3, pp. 1453–1460, 2002.
- G. R. Cornelis, “The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense,” Folia Microbiologica, vol. 43, no. 3, pp. 253–261, 1998.
- R. R. Brubaker, “Factors promoting acute and chronic diseases caused by yersiniae,” Clinical Microbiology Reviews, vol. 4, no. 3, pp. 309–324, 1991.
- J. F. Wong and S. S. Elberg, “Cellular immune response to Yersinia pestis modulated by product(s) from thymus derived lymphocytes,” Journal of Infectious Diseases, vol. 135, no. 1, pp. 67–78, 1977.
- S. T. Smiley, “Cell-mediated defense against Yersinia pestis infection,” Advances in Experimental Medicine and Biology, vol. 603, pp. 376–386, 2007.
- R. Nakajima and R. R. Brubaker, “Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha,” Infection and Immunity, vol. 61, no. 1, pp. 23–31, 1993.
- G. R. Cornelis, “Yersinia type III secretion: send in the effectors,” Journal of Cell Biology, vol. 158, no. 3, pp. 401–408, 2002.
- G. R. Cornelis, “The Yersinia YSC-YOP ‘type III’ weaponry,” Nature Reviews Molecular Cell Biology, vol. 3, no. 10, pp. 742–752, 2002.
- M. Aepfelbacher, R. Zumbihl, and J. Heesemann, “Modulation of Rho GTPases and the actin cytoskeleton by YopT of Yersinia,” Current Topics in Microbiology and Immunology, vol. 291, pp. 167–175, 2005.
- A. A. Fadl, C. L. Galindo, J. Sha, G. R. Klimpel, V. L. Popov, and A. K. Chopra, “Global gene expression of a murein (Braun) lipoprotein mutant of Salmonella enterica serovar Typhimurium by microarray analysis,” Gene, vol. 374, no. 1-2, pp. 121–127, 2006.
- H. Zhang, I. Kaur, D. W. Niesel, et al., “Lipoprotein from Yersinia enterocolitica contains epitopes that cross-react with the human thyrotropin receptor,” Journal of Immunology, vol. 158, no. 4, pp. 1976–1983, 1997.
- A. O. Aliprantis, R.-B. Yang, M. R. Mark, et al., “Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2,” Science, vol. 285, no. 5428, pp. 736–739, 1999.
- J. Sha, S. L. Agar, W. B. Baze, et al., “Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague,” Infection and Immunity, vol. 76, no. 4, pp. 1390–1409, 2008.
- H. Liu, H. Wang, J. Qiu, et al., “Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host,” Journal of Basic Microbiology, vol. 49, no. 1, pp. 92–99, 2009.
- T. Liu, S. L. Agar, J. Sha, and A. K. Chopra, “Deletion of Braun lipoprotein gene (lpp) attenuates Yersinia pestis KIM/D27 strain: role of Lpp in modulating host immune response, NF-B activation and cell death,” Microbial Pathogenesis, vol. 48, no. 1, pp. 42–52, 2010.
- F. M. Campbell, M. Waterston, L. O. Andresen, N. S. Sorensen, P. M. H. Heegaard, and P. D. Eckersall, “The negative acute phase response of serum transthyretin following Streptococcus suis infection in the pig,” Veterinary Research, vol. 36, no. 4, pp. 657–664, 2005.
- L. Lalier, P.-F. Cartron, F. Pedelaborde, et al., “Increase in PGE2 biosynthesis induces a Bax dependent apoptosis correlated to patients' survival in glioblastoma multiforme,” Oncogene, vol. 26, no. 34, pp. 4999–5009, 2007.
- S. J. Myung and I. H. Kim, “Role of prostaglandins in colon cancer,” The Korean Journal of Gastroenterology, vol. 51, no. 5, pp. 274–279, 2008.
- E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper, “Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock,” Clinical Microbiology Reviews, vol. 16, no. 3, pp. 379–414, 2003.
- A. Sing, D. Reithmeier-Rost, K. Granfors, J. Hill, A. Roggenkamp, and J. Heesemann, “A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 44, pp. 16049–16054, 2005.
- D. Reithmeier-Rost, J. Hill, S. J. Elvin, et al., “The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis,” Microbes and Infection, vol. 9, no. 8, pp. 997–1002, 2007.
- J. A. Hamerman, F. Hayashi, L. A. Schroeder, et al., “Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog,” Journal of Immunology, vol. 168, no. 5, pp. 2415–2423, 2002.
- G. Trinchieri, “Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-),” Current Opinion in Immunology, vol. 9, no. 1, pp. 17–23, 1997.
- E. Jouanguy, R. Doffinger, S. Dupuis, A. Pallier, F. Altare, and J. L. Casanova, “IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men,” Current Opinion in Immunology, vol. 11, no. 3, pp. 346–351, 1999.
- N. Liu, Y. Wang, and P. G. Ashton-Rickardt, “Serine protease inhibitor 2A inhibits caspase-independent cell death,” FEBS Letters, vol. 569, no. 1–3, pp. 49–53, 2004.
- N. Liu, T. Phillips, M. Zhang, et al., “Serine protease inhibitor 2A is a protective factor for memory T cell development,” Nature Immunology, vol. 5, no. 9, pp. 919–926, 2004.
- E. Guenzi, K. Töpolt, E. Cornali, et al., “The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines,” EMBO Journal, vol. 20, no. 20, pp. 5568–5577, 2001.
- F. Aberger, A. P. Costa-Pereira, J. F. Schlaak, et al., “Analysis of gene expression using high-density and IFN--specific low-density cDNA arrays,” Genomics, vol. 77, no. 1-2, pp. 50–57, 2001.
- S. Martens, I. Parvanova, J. Zerrahn, et al., “Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases,” PLoS Pathogens, vol. 1, no. 3, article e24, 2005.
- Y. M. Ling, M. H. Shaw, C. Ayala, et al., “Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages,” Journal of Experimental Medicine, vol. 203, no. 9, pp. 2063–2071, 2006.
- R. A. Lukaszewski, D. J. Kenny, R. Taylor, D. G. C. Rees, M. G. Hartley, and P. C. F. Oyston, “Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils,” Infection and Immunity, vol. 73, no. 11, pp. 7142–7150, 2005.
- B. J. Hinnebusch, “Bubonic plague: a molecular genetic case history of the emergence of an infectious disease,” Journal of Molecular Medicine, vol. 75, no. 9, pp. 645–652, 1997.
- G. Papanikolaou, M. E. Samuels, E. H. Ludwig, et al., “Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis,” Nature Genetics, vol. 36, no. 1, pp. 77–82, 2004.
- S. L. Agar, J. Sha, W. B. Baze, et al., “Deletion of Braun lipoprotein gene (lpp) and curing of pPCP1 dramatically alter the virulence of Yersinia pestis CO92 in a mouse model of pneumonic plague,” Microbiology, vol. 155, no. 10, pp. 3247–3259, 2009.
- E. C. Pietsch, E. Perchiniak, A. A. Canutescu, G. Wang, R. L. Dunbrack, and M. E. Murphy, “Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain,” Journal of Biological Chemistry, vol. 283, no. 30, pp. 21294–21304, 2008.
- S. Abu-Hamad, H. Zaid, A. Israelson, E. Nahon, and V. Shoshan-Barmatz, “Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding,” Journal of Biological Chemistry, vol. 283, no. 19, pp. 13482–13490, 2008.